HEALTHCARE is a great value right now
Medical device manufacturer offers good value in the healthcare sector, which is poised for growth driven by demographic trends (aging population) and AI-enhanced product opportunities.
Past performance does not predict future results. Informational only, not investment advice.
Medical device manufacturer offers good value in the healthcare sector, which is poised for growth driven by demographic trends (aging population) and AI-enhanced product opportunities.
Medtronic trades at a cheap 13x forward earnings with a 7% free-cash-flow yield, but growth is slowing to 4% and main products lack momentum. Investors may want to wait until growth trends improve before entering.
Medtronic has declined 20% this year amid GLP-1 drug concerns and tariff pressures, but its cardiology and neurology focus provides resistance to those headwinds. Trading at 13x forward earnings with a 3.7% yield, the stock offers value as profit growth is expected to accelerate to 10% next fiscal year.
End of results.